Literature DB >> 18973072

Drug utilization review of cholinesterase inhibitors in Quebec.

Fadi Massoud, Marc Dorais, Claudie Charbonneau, Bénédicte Lescrauwaet, Jean-Marc Boucher, Jacques LeLorier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18973072     DOI： 10.1017/s0317167100009215

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN： 0317-1671            Impact factor:   2.104


× No keyword cloud information.
  7 in total

1.  Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study.

Authors:  Edeltraut Kröger; Rob van Marum; Patrick Souverein; Toine Egberts
Journal:  Drugs Aging       Date:  2010-08-01       Impact factor: 3.923

Review 2.  Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia.

Authors:  Carl H Sadowsky; Joseph L Micca; George T Grossberg; Drew M Velting
Journal:  Prim Care Companion CNS Disord       Date:  2014-09-04

3.  Care of dementia in Canada: a collaborative care approach with a central role for the primary care physician.

Authors:  F Massoud; P Lysy; H Bergman
Journal:  J Nutr Health Aging       Date:  2010-02       Impact factor: 4.075

4.  Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching.

Authors:  Anat Fisher; Greg Carney; Ken Bassett; Colin R Dormuth
Journal:  Drugs Aging       Date:  2017-03       Impact factor: 3.923

Review 5.  Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factors.

Authors:  Colleen J Maxwell; Kathryn Stock; Dallas Seitz; Nathan Herrmann
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

6.  Update on the pharmacological treatment of Alzheimer's disease.

Authors:  Fadi Massoud; Serge Gauthier
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

7.  Real-world evaluation of compliance and preference in Alzheimer's disease treatment.

Authors:  Ming-Chyi Pai; Hany Aref; Nazem Bassil; Nagaendran Kandiah; Jae-Hong Lee; A V Srinivasan; Shelley diTommaso; Ozgur Yuksel
Journal:  Clin Interv Aging       Date:  2015-11-03       Impact factor: 4.458
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.